Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech IncfiledCriticalJanssen Biotech Inc
Priority claimed from PCT/IB2020/050310external-prioritypatent/WO2020148677A1/en
Publication of CR20210382ApublicationCriticalpatent/CR20210382A/es
101710174800G-protein coupled receptor family C group 5 member DProteins0.000abstract1
101001040713Homo sapiens G-protein coupled receptor family C group 5 member DProteins0.000abstract1
206010028980NeoplasmDiseases0.000abstract1
201000011510cancerDiseases0.000abstract1
Landscapes
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Receptores de antígeno quimérico (CAR) que se dirigen específicamente a un miembro D del grupo 5 de la familia C (GPRC5D) del receptor acoplado a la proteína G, y células inmunosensibles que comprenden tales CAR, para el tratamiento del cáncer.
CR20210382A2019-01-182020-01-15Receptores de antígenos quiméricos de gprc5d y células que los expresan
CR20210382A
(es)